Clinical Trials Browser

Interventional × Adenocarcinoma × Cetuximab × Clear all

NCT01442649 2022-01-11

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT01442935 2021-06-18

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT00395252 2015-10-02

ATIP

Phase 2 Completed

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT00716456 2015-04-30

Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib

Phase 1/2 Completed

21 enrolled 8 charts

Adenocarcinoma of Lung, Adenocarcinoma, Lung Neoplasms